Profund Advisors’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
Other funds holding BLUE
GIM
PAI
TCM
Profund Advisors's BLUE Position: Q1 2024 in Review
Profund Advisors sold out of bluebird bio (BLUE) in Q1 2024, closing a stake of 10,422 shares — an estimated $288K sold.
Profund Advisors first reported a position in BLUE in Q3 2015 and held it in 28 quarters. The position peaked at $3.43M in Q4 2017. 158 funds tracked by Wall St. Rank hold BLUE as of Q1 2024.
- Profund Advisors reported no remaining bluebird bio position as of Q1 2024 after selling out during the quarter.
- Profund Advisors sold 10,422 bluebird bio shares in Q1 2024, an estimated $288K.
- Profund Advisors first reported a position in bluebird bio in Q3 2015 and held it in 28 quarters.
- Profund Advisors's bluebird bio position peaked at $3.43M in Q4 2017.
- 158 funds tracked by Wall St. Rank held bluebird bio as of Q1 2024.
Based on Profund Advisors's 13F filing for Q1 2024, filed 8 May 2024.